Giada Cabrino, an analyst from Intesa Sanpaolo, maintained the Buy rating on Fine Foods & Pharmaceuticals N.T.M. SpA. The associated price target is €12.80.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Giada Cabrino has given her Buy rating due to a combination of factors that highlight Fine Foods & Pharmaceuticals N.T.M. SpA’s strong financial performance and growth potential. The company reported impressive revenue growth in the third quarter of 2025, surpassing expectations, with a notable increase in the adjusted EBITDA margin. Despite significant investments aimed at expanding production capabilities, the company has maintained control over its net debt, indicating financial stability.
Additionally, the company’s various business units, particularly the Pharma and Cosmetics divisions, have demonstrated robust growth, contributing to an overall positive outlook. The completion of the Pharma site expansion and regulatory approvals further bolster future revenue prospects. With a strategic focus on leveraging synergies across its business units and capitalizing on market trends, Fine Foods & Pharmaceuticals N.T.M. is well-positioned for continued success. Consequently, the updated target price reflects these optimistic projections and the company’s strategic investments in key markets.
According to TipRanks, Cabrino is a 3-star analyst with an average return of 3.7% and a 48.44% success rate. Cabrino covers the Industrials sector, focusing on stocks such as TraWell Co S.p.A., SIT S.p.A., and EdiliziAcrobatica SpA.